Also found in: Thesaurus, Medical, Wikipedia.
Related to ondansetron: ondansetron HCl


A selective serotonin receptor antagonist, C18H19N3O, used in its hydrochloride form to prevent nausea and vomiting, especially when occurring postoperatively or as a result of chemotherapy or radiotherapy.

[ondan-, of unknown origin + -setron (from (se(ro)t(onin) r(eceptor antag)on(ist)).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n ondansetrón m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Objective: To compare the efficacy of ondansetron with a combination of ondansetron and dexamethasone after elective laparoscopic cholecystectomy in terms of postoperative nausea and vomiting.
2, 2018 (HealthDay News) -- Use of ondansetron for the treatment of nausea and vomiting in pregnancy does not appear to be associated with birth defects, according to research published in the August issue of Obstetrics & Gynecology.
Some studies showed that aprepitant is significantly more effective than ondansetron, a serotonin (5-H[T.sub.3]) receptor antagonist, for the prevention of postoperative vomiting in open abdominal surgery (10, 11).
One of the choices for such treatment has been ondansetron, a 5-HT3 receptor antagonist, which has been used off label for NVP and is now available in generic form.
The affected drugs include: Azithromycin, Donepezil, Haloperidol, Imipramine HCl, Isosorbide Dinitrate, Naratriptan, Ondansetron, Perphenazine, and Risperidone.
Ondansetron is a carbazalone derivative that is structurally similar to serotonin and possess specific 5HT3 receptor antagonistic properties.
Objective: To evaluate the association of anti-emetic efficacy of ondansetron with 18792A>G polymorphism in the target gene of 5-hydroxytryptamine type 3 subtype B.
The first presentation, entitled 'Treatment of Acute Gastroenteritis-Related Emesis with Bimodal Release Ondansetron', will be presented by Robert Silverman, MD, MS, Associate Professor of Emergency Medicine, Zucker School of Medicine at Hofstra/Northwell; Northwell Health, and Lead Investigator of the BEKINDA Phase III GUARD study, on Wednesday, May 16, 2018, at 3:00 PM EDT.
Dexamethasone and ondansetron are commonly used for prophylaxis of PONV [9-13] due to their negligible adverse effects.
Sufferers are often given ondansetron, which was developed to tackle post-chemo vomiting.
These lesions followed multiple erythematous plaques over the same areas which appeared within 4 hours of the intake of an ondansetron tablet, 12 days previously.
A detailed review of medication administration records revealed that all patients received 4 intravenous medications: ondansetron, heparin, saline, and potassium.